Literature DB >> 15950907

Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).

Alberto Martín1, Junko Odajima, Sarah L Hunt, Pierre Dubus, Sagrario Ortega, Marcos Malumbres, Mariano Barbacid.   

Abstract

p27(Kip1) and p21(Cip1) are thought to suppress tumor growth and prevent cell cycle progression by inhibiting Cdk2-cyclin E/A kinases. Since Cdk2 is dispensable for mitotic cell division, we analyzed the activity of these inhibitors in Cdk2-deficient cells. Ectopic expression of p27(Kip1) or p21(Cip1) efficiently inhibits cell cycle progression of Cdk2(-/-) fibroblasts. Loss of p27(Kip1) or p21(Cip1) confers similar proliferative advantages to Cdk2(+/+) and Cdk2(-/-) cells. Moreover, Cdk2 is dispensable for p21(Cip1)-induced cell cycle arrest after DNA damage. Finally, ablation of Cdk2 in p27(Kip1) null mice does not suppress their phenotypic defects, including development of pituitary tumors. These results indicate that Cdk2 is not an essential target for p27(Kip1) and p21(Cip1) in cell cycle inhibition and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950907     DOI: 10.1016/j.ccr.2005.05.006

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

1.  Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.

Authors:  María J Bueno; Marta Gómez de Cedrón; Usua Laresgoiti; José Fernández-Piqueras; Ana M Zubiaga; Marcos Malumbres
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

2.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

Review 3.  G1 to S phase cell cycle transition in somatic and embryonic stem cells.

Authors:  Irina Neganova; Majlinda Lako
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

Review 4.  Functional evolution of cyclin-dependent kinases.

Authors:  John H Doonan; Georgios Kitsios
Journal:  Mol Biotechnol       Date:  2009-01-15       Impact factor: 2.695

Review 5.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

6.  Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2/STAT3 signaling pathway.

Authors:  You-Li Xie; Wen-Hui Tao; Ti-Xiong Yang; Jian-Guo Qiao
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

7.  P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases.

Authors:  Debora Bencivenga; Annunziata Tramontano; Alessia Borgia; Aide Negri; Ilaria Caldarelli; Adriana Oliva; Silverio Perrotta; Fulvio Della Ragione; Adriana Borriello
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Authors:  Stefano Campaner; Mirko Doni; Per Hydbring; Alessandro Verrecchia; Lucia Bianchi; Domenico Sardella; Thomas Schleker; Daniele Perna; Susanna Tronnersjö; Matilde Murga; Oscar Fernandez-Capetillo; Mariano Barbacid; Lars-Gunnar Larsson; Bruno Amati
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

Review 9.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

10.  Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27.

Authors:  Sangjin Lee; Tri M Bui Nguyen; Dmitry Kovalenko; Neeta Adhikari; Suzanne Grindle; Sean P Polster; Robert Friesel; Sundaram Ramakrishnan; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2010-01-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.